Healing & Recovery Peptides: Evidence-Based Research Guide
Peptides studied for tissue repair, wound healing, and injury recovery represent one of the most active areas of preclinical peptide research. Compounds like BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu have been investigated in animal models for their potential to accelerate healing of tendons, muscles, ligaments, and skin. While none are FDA-approved for human therapeutic use, the volume of preclinical evidence has generated significant interest from researchers and clinicians.
3 compounds in this category
BPC-157Body Protection Compound-157, Bepecin
A gastric pentadecapeptide studied extensively in animal models for tissue healing, gut protection, and cytoprotective properties. Despite over 100 preclinical studies, human clinical data remains extremely limited.
TB-500Thymosin Beta-4, TB4
A naturally occurring peptide central to cell migration and tissue repair. Phase 2 human wound healing trials showed accelerated healing; also studied for cardiac and corneal repair.
GHK-CuCopper Peptide, Glycyl-L-histidyl-L-lysine:copper(II)
A naturally occurring copper-binding tripeptide with research supporting skin remodeling, wound healing, and anti-aging properties.